Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.160
-0.020 (-1.69%)
At close: Jul 13, 2026, 4:00 PM EDT
1.170
+0.010 (0.86%)
After-hours: Jul 13, 2026, 4:38 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $4.41 million as of July 13, 2026. Its market cap has increased by 88.71% in one year.
Market Cap
4.41M
Enterprise Value
1.70M
1-Year Change
88.71%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $4.41M, a decrease of -99.62%. That is a compound annual growth rate of -66.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 4.41M | -36.21% |
| Dec 31, 2025 | 6.92M | 9.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 5.09M |
| Evogene | 4.98M |
| Bio Green Med Solution | 4.97M |
| Enveric Biosciences | 4.97M |
| Alaunos Therapeutics | 4.97M |
| FibroBiologics | 4.95M |
| Aptevo Therapeutics | 4.91M |
| Matinas BioPharma Holdings | 4.84M |